Manufacturers Life Insurance Company, The Madrigal Pharmaceuticals, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 29,957 shares of MDGL stock, worth $9.75 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
29,957
Previous 35,678
16.04%
Holding current value
$9.75 Million
Previous $10 Million
36.4%
% of portfolio
0.01%
Previous 0.01%
Shares
32 transactions
Others Institutions Holding MDGL
# of Institutions
296Shares Held
21.9MCall Options Held
819KPut Options Held
644K-
Janus Henderson Group PLC London, X02.48MShares$807 Million0.28% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.04MShares$665 Million29.57% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.03MShares$660 Million6.48% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$649 Million6.74% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$643 Million4.49% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.57B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...